+202.7%
RCAT vs BBIO
+42.7%
+159.9%
-84.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.5% | -0.1% | -1.4% | -1.5% |
| 7D | -4.9% | -3.2% | -1.7% | -4.5% |
| 30D | -22.9% | -13.6% | -9.3% | -21.5% |
| 3M | -33.7% | +7.2% | -41.0% | -34.4% |
| 6M | -50.7% | +1.5% | -52.2% | -50.9% |
| YTD | +0.4% | -5.3% | +5.7% | +0.6% |
| 1Y | -27.6% | +37.7% | -65.4% | -30.4% |
| 3Y | +753.2% | +153.9% | +599.3% | +652.4% |
| All | +202.7% | +42.7% | +159.9% | +141.4% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling